AYALA, FABIO
 Distribuzione geografica
Continente #
EU - Europa 2.673
NA - Nord America 1.429
AS - Asia 1.155
SA - Sud America 213
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 5.491
Nazione #
RU - Federazione Russa 1.979
US - Stati Uniti d'America 1.414
SG - Singapore 477
IE - Irlanda 371
HK - Hong Kong 251
CN - Cina 195
BR - Brasile 182
GB - Regno Unito 133
VN - Vietnam 107
DE - Germania 78
KR - Corea 41
FI - Finlandia 31
JP - Giappone 30
IT - Italia 26
AR - Argentina 15
BD - Bangladesh 13
BE - Belgio 11
SE - Svezia 11
IN - India 7
IQ - Iraq 7
CA - Canada 6
ID - Indonesia 6
FR - Francia 5
MX - Messico 5
TR - Turchia 5
AZ - Azerbaigian 4
CL - Cile 4
EC - Ecuador 4
ES - Italia 4
RS - Serbia 4
TN - Tunisia 4
UA - Ucraina 4
AT - Austria 3
EE - Estonia 3
EU - Europa 3
PK - Pakistan 3
UY - Uruguay 3
ZA - Sudafrica 3
BO - Bolivia 2
HU - Ungheria 2
JM - Giamaica 2
JO - Giordania 2
LB - Libano 2
NL - Olanda 2
SK - Slovacchia (Repubblica Slovacca) 2
AO - Angola 1
AU - Australia 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CO - Colombia 1
DZ - Algeria 1
EG - Egitto 1
HN - Honduras 1
KE - Kenya 1
KG - Kirghizistan 1
LT - Lituania 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PL - Polonia 1
PT - Portogallo 1
RE - Reunion 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.491
Città #
Moscow 689
Dublin 371
Chandler 321
Hong Kong 249
Santa Clara 239
Singapore 197
San Jose 119
Ashburn 69
Bremen 59
Cambridge 59
Princeton 59
Roxbury 59
Dallas 55
Beijing 43
Seoul 41
Ho Chi Minh City 39
Hanoi 23
Des Moines 20
Helsinki 18
Wilmington 18
São Paulo 15
Espoo 13
Munich 13
Ann Arbor 11
Brussels 11
Columbus 9
Belo Horizonte 8
Boston 8
The Dalles 7
Los Angeles 6
Milan 6
Shanghai 6
Atlanta 5
Rio de Janeiro 5
Tokyo 5
Biên Hòa 4
Da Nang 4
Falkenstein 4
Guangzhou 4
Haiphong 4
Stockholm 4
Baku 3
Belgrade 3
Changsha 3
Curitiba 3
Hải Dương 3
London 3
Maceió 3
Manchester 3
Montevideo 3
Nha Trang 3
Norwalk 3
Porto Alegre 3
Presidente Prudente 3
Tunis 3
Valparaíso de Goiás 3
Amman 2
Ankara 2
Aracaju 2
Arezzo 2
Bandung 2
Baoding 2
Bexley 2
Brooklyn 2
Campo Grande 2
Can Tho 2
Caratinga 2
Chapecó 2
Chicago 2
Clifton 2
Duque de Caxias 2
Fazenda Rio Grande 2
Guarulhos 2
Ha Long 2
Hangzhou 2
Istanbul 2
Itapetinga 2
Johannesburg 2
Joinville 2
Kyiv 2
Lấp Vò 2
Monte Grande 2
Multan 2
New York 2
Ninh Bình 2
Perugia 2
Petrópolis 2
Phoenix 2
Phủ Lý 2
Piscataway 2
Praia Grande 2
Quảng Ngãi 2
Salvador 2
Santana do Livramento 2
Santiago 2
Secaucus 2
Sete Lagoas 2
Shenzhen 2
St Louis 2
Vienna 2
Totale 3.032
Nome #
'Eczemas' and leptin 142
Acrodermatitis continua of Hallopeau respondind to efalizumab therapy 140
Abnormal isoaspartyl residues in erythrocyte membranes from psoriasi patients 137
Dermoscopy experts vs dermoscopy non-experts: A comparison between face-to-face diagnosis and telediagnosis for the observation of "pink'' lesions 133
Contact sensitization in the elderly 132
Chronic hand Eczema: Is IL-36á helpful in diagnosis and classification? 127
Contact sensitization of children referred to the Dermatology Department of the University Federico II of Naples, Italy: a two-decade years history 126
Contact sensitization of older patients in an academic department in Naples 123
Climate change and skin 123
Crosstalk between skin inflammation and adipose tissue-derived products: pathogenic evidence linking psoriasis to increased adiposity 120
Educational and motivational support service: a pilot study for mobile-phone-based interventions in patients with psoriasis 120
Patch test results with fragrance markers of the baseline series - Analysis of the European Surveillance System on Contact Allergies (ESSCA) network 2009-2012 119
Current patch test results with the European baseline series and extensions to it from the 'European Surveillance System on Contact Allergy' network, 2007-2008 118
Pitfalls in patch testing 117
Differences between the glycosylation patterns of haptoglobin isolated from skin scales and plasma of psoriatic patients 115
Efficacy and safety of ustekinumab in a group of 22 elderly patients with psoriasis over a 2-year period 114
Development of primary varicella infection during infliximab treatment for psoriasis 114
Effects of adalimumab therapy in adult subjects with moderate-to-severe psoriasis on Th17 pathway 114
Biologics that inhibit the Th17 pathway and related cytokines to treat inflammatory disorders 113
Chromatin Assembly Factor-1/p60 overexpression: a potential index of psoriasis severity 113
Effects of climate changes on skin diseases 107
Aquagenic wrinkling of the palms: a case report and literature review 105
Psoriasis in elderly and non elderly population: clinical and molecular features 101
Systemic Treatment of Adult Atopic Dermatitis: A Review 100
Telediagnosis and face-to-face diagnosis reliability for "pink'' lesions 96
Role of single-immunoglobulin interleukin-1 related receptor (SIGIRR) in psoriasis 93
Psoriasis in melanoma patients: a prospective pilot study 89
IL-33 and IL-1F9 in allergic contact dermatitis 87
Pizza Makers? Contact Dermatitis 86
Systemic Treatment of Pediatric Psoriasis: A Review 86
Multiple sclerosis following anti-tumor necrosis factor-alpha therapy for psoriasis: first case in Italy? 84
Erythema multiforme-like eruption because of para-phenylenediamine 84
Psoriasis and melanocytic naevi: does the first confer a protective role against melanocyte progression to naevi? 84
Psoriasis and osteoporosis: data from a Southern Italian population 83
RAST: Clinical applications 83
Minimal disease activity in patients with psoriatic arthritis treated with ustekinumab: results from a 24-week real-world study 82
The balance between pro- and anti-inflammatory cytokines is crucial in human allergic contact dermatitis pathogenesis: the role of IL-1 family members 80
The effects of etanercept on replication, proliferation, survival, and apoptosis markers in moderate to severe psoriasis 79
Understanding the role of haptoglobin in psoriasis: effects of ultraviolet B 78
Mechanistic target of rapamycin complex 1 is involved in psoriasis and regulated by anti-TNF-α treatment 78
IL-36γ Is Involved in Psoriasis and Allergic Contact Dermatitis 77
IL-26: A new actor in allergic contact dermatitis 76
European Surveillance System on Contact Allergies (ESSCA): polysensitization, 2009-2014 76
Psoriatic disease and tuberculosis nowadays 76
IL-33 is secreted by psoriatic keratinocytes and induces pro-inflammatory cytokines via keratinocyte and mast cell activation 74
Visceral Leishmaniasis Infection in a Patient with Psoriasis Treated with Efalizumab 73
Instrument-related Skin Disorders in Musicians 71
Interleukin-33: increasing role in dermatological conditions 70
Psoriasis in Children: a Review 70
Polymorphic light eruption and innate immunity: the role of interleukin-1 family 69
The European vaseline series in 10 European Countries, 2005/2006 – Results of the European Surveillance System on contact Allergies (ESSCA). Contct Dermatitis 61:31-38, 2009 69
Interleukin-1 family members are enhanced in psoriasis and suppressed by vitamin D and retinoic acid 68
Psoriasis or "psoriases"? 68
From the skin to the bone: Pro-osteoclastogenesis inflammatory march 66
Pathogenesis of Psoriasis: The Role of Pro-Inflammatory Cytokines Produced by Keratinocytes 66
IL-33 is regulated by TNF-α in normal and psoriatic skin 65
Psoriasis and Skin Pain: Instrumental and Biological Evaluations 65
IL-33 effects in psoriasis: The induction of pro-inflammatory cytokines via keratinocyte and mast cell activation 64
Rational ideation and empiric validation of an innovative digital dermographic tester 64
Totale 5.552
Categoria #
all - tutte 22.022
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.022


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022379 0 59 3 0 125 5 6 11 9 5 20 136
2022/2023878 66 43 7 106 114 86 0 50 366 5 21 14
2023/2024239 27 7 8 9 105 0 3 0 2 7 23 48
2024/2025999 0 3 2 47 166 152 133 94 200 86 62 54
2025/20263.056 84 65 165 117 275 1.889 176 39 122 51 45 28
2026/20271 1 0 0 0 0 0 0 0 0 0 0 0
Totale 5.552